Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ABX464 First in Man, Open Label, Parallel Group, Single Ascending Dose Study

NCT02792686 is registered in ClinicalTrials.gov with Abivax S.A. as lead sponsor.

NCT NCT02792686
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02792686 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ABX464 First in Man, Open Label, Parallel Group, Single Ascending Dose Study
Lead sponsor
Abivax S.A.
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2014
Completion date
July 31, 2014
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers